Form 4: National Research Corp CEO Acquires Stock Options

National Research Corp's CEO, Michael D. Hays, was granted 11,021 stock options on January 10, 2025, which will become fully exercisable on January 10, 2030.

Summary

• Michael D. Hays, CEO and President of National Research Corp, was granted 11,021 employee stock options on January 10, 2025.
• The exercise price of these options is $17.34 per share.
• The options will become fully exercisable on January 10, 2030.
• The options expire on January 10, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There is no indication of any negative sentiment.

Positives

• The granting of stock options to the CEO aligns his interests with those of the shareholders.
• The vesting period of five years may encourage long-term performance and commitment from the CEO.

Future Outlook

The stock options will become exercisable in the future, subject to the vesting schedule.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies.

Comparison to Industry Standards

• Stock option grants are a standard practice for aligning executive compensation with company performance.
• The vesting period of five years is within the typical range for such grants.

Stakeholder Impact

• The stock option grant may positively impact shareholder confidence by aligning the CEO's interests with the company's long-term success.
• The grant does not have any immediate impact on employees, customers, suppliers or creditors.

Key Dates

Keywords

stock options, executive compensation, insider trading, National Research Corp, CEO, Michael D. Hays